1 |
Aronica, M. A., S. McCarthy, S. Swaidani, D. Mitchell, M. Goral, J. R. Sheller, and M. Boothby. 2004. Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. Am. J. Respir. Crit. Care Med. 169: 587-595
DOI
ScienceOn
|
2 |
Barnes, P. J. 2000. Endogenous inhibitory mechanisms in asthma. Am. J. Respir. Crit. Care Med. 161: S176-181
DOI
|
3 |
Borish, L. 2003. Allergic rhinitis: Systemic inflammation and implications for management. J. Allergy Clin. Immunol. 112: 1021-1031
DOI
ScienceOn
|
4 |
de Heer, H. J., H. Hamida, S. Thomas, J. Danielle, V. Nanda, A. M. W. Monique, C. H. Henk, and N. L. Bart. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 5: 89-98
|
5 |
de Sousa, A. C., D. S. Alviano, A. F. Blank, P. B. Alves, C. S. Alviano, and C. R. Gattass. 2004. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J. Pharm. Pharmacol. 56: 677-681
DOI
ScienceOn
|
6 |
Duan, W., J. H. Chan, C. H. Wonq, B. P. Leung, and W. S. Wonq. 2004. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J. Immunol. 172: 7053-7059
DOI
PUBMED
|
7 |
Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Mattaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201
DOI
ScienceOn
|
8 |
Huang, M. T., V. Badmaev, Y. Ding, Y. Liu, J. G. Xie, and C. T. Ho. 2000. Anti-tumor and anti-carcinogenic acitivity of triterpenoid, beta boswellic acid. Biofactors. 13: 225-230
DOI
|
9 |
Kibe, A., H. Inoue, S. Fukuyama, K. Machida, K. Matsumoto, H. Koto, T. Ikeqami, H. Aizawa, and N. Hara. 2003. Differential regulation by glucocorticoid of interleukin- 13-induced eosinophilia: hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am. J. Respir. Crit. Care Med. 167: 50-56
DOI
ScienceOn
|
10 |
Kim, J., H. Lee, Y. Lee, B. G. Oh, C. Cho, Y. Kim, M. Shin, M. Hong, S. K. Jung and H. Bae. 2007. Inhibition effects of Moutan Cortex Radicis on secretion of eotaxin in A549 humna epithelial cells and eosinophil migration. J. Ethnopharmacol. 114: 186-193
DOI
ScienceOn
|
11 |
Maruyama, N., Y. Sekimoto, H. Ishibashi, S. Inouye, H. Oshima, H. Yamaquchi, and S. Abe. 2005. Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil. J. Inflamm. (Lond). 2: 1-11
DOI
ScienceOn
|
12 |
Paul, J. B., G. Raif, and C. O. Hans. 2003. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J. Allergy Clin. Immunol. 112: 149-159
DOI
ScienceOn
|
13 |
Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar Tlymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304
DOI
PUBMED
ScienceOn
|
14 |
Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169: 6482-6489
DOI
PUBMED
|
15 |
Roh, G. S., S. W. Seo, S. Yeo, J. M. Lee, J. W. Choi, E. Kim, Y. Shin, C. Cho, H. Bae, S. K. Jung, and K. Kwack. 2005. Efficacy of a traditional Korean medicine, Chung-Sang-Bo- Ha-Tang, in a murine model of chronic asthma. Int. Immunopharmacol. 5: 427-436
DOI
ScienceOn
|
16 |
Singh, G. B., S. Singh, and S. Bani. 1996. Anti-inflammatroy actions of boswellic acids. Phytomedicine 3: 81-85
DOI
ScienceOn
|
17 |
Takami, M., Y. Takata, K. Matsumoto, S. Ono, and W. Tsukada. 1991. Effects of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. Ann. N. Y. Acad. Sc. 629: 407-409
DOI
|
18 |
van Schayck, C. P., I. D. Bijl-Hofland, S. G. Cloosterman, H. T. Folqering, F. J. vad der Elshout, and C. Van Weel. 2002. Potential masking effect on dyspnoea perception by shortand long-acting beta2-agonists in asthma. Eur. Respir. J. 19: 240-245
DOI
ScienceOn
|
19 |
Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, J. C. Jr. Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveloar lavage. Am. Rev. Respir. Dis. 146: 109-115
DOI
PUBMED
ScienceOn
|
20 |
Redington, A. E., and P. H. Howarth. Airway wall remodeling in asthma. Thorax. 52: 310-312
DOI
PUBMED
ScienceOn
|
21 |
Yang, M., S. P. Hogan, S. Mahalingam, S. M. Pope, N. Zimmermann, P. Fulkerson, L. A. Dent, I. G. Young, K. I. Mattaei, M. E. Rothenberg, and P. S. Foster. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy. Clin. Immunol. 112: 935-943
DOI
ScienceOn
|
22 |
Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, and A. Sirotina. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183: 2349-2354
DOI
ScienceOn
|
23 |
Bousquet, J., P. Chanez, J. Y. Lacoste, R. White, P. Vic, P. Godard, and F. B. Michel. 1992. Asthma: a disease remodeling the airways. Allergy. 47: 3-11
PUBMED
|
24 |
Palmerio, E. M., R. J. Hopp, R. E. Biven, A. K. Bewtra, N. N. Nair, and R. G. Townley. 1992. Probability of asthma based on methacholine challenge. Chest. 101: 630-633
DOI
ScienceOn
|
25 |
Roche, W. R., R. Beasley, J. H. Wiliams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1: 520-524
PUBMED
|
26 |
Barnes, P. J. 1999. Therapeutic strategy for allergic disease. Nature. 402: B31-38 (Suppl.)
|
27 |
Busse, W. W., and R. F. Jr. Lemanske. 2001. Asthma. N. Engl. J. Med. 344: 350-362
DOI
ScienceOn
|
28 |
Won, J., Y. G. Hur, E. M. Hur, S. H. Park, M. A. Kang, Y. Choi, C. Park, K. H. Lee, and Y. Yun. 2003. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur. J. Immunol. 33: 870-879
DOI
ScienceOn
|
29 |
Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma, From bronchoconstriction to airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745
DOI
PUBMED
ScienceOn
|
30 |
Tucker, A. O., 1986. Frankincense and myrrh. Econ. Bot. 40: 425-433
DOI
|
31 |
Bromberg, J. S. 1993. The biology of CD2: adhesion, transmembrane signal, and regulatory receptor of immunity. J. Surg. Res. 54: 258-267
DOI
ScienceOn
|
32 |
Roy, S., S. Khanna, H. Shah, C. Rink, C. Phillips, H. Preuss, G. V. Subbaraju, G. Trimurtulu, A. V. Krishnaraju, M. Baqchi, D. Baqchi, and C. K. Sen. 2005. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 24: 244-255
DOI
ScienceOn
|
33 |
Scola, A. M., L. K. Chong, S. K. Suvarna, R. Chess-Williams, and P. T. Peachell. 2004. Desensitisation of mast cell beta2- adrenorceptor-mediated responses by salmeterol and formoterol. Br. J. Pharmacol. 141: 163-171
DOI
ScienceOn
|
34 |
Abe, S., N. Maruyama, K. Hayama, H. Ishibashi, S. Inoue, H. Oshima, and H. Yamaguchi. 2003. Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Med. Inflamm. 12: 323-328
DOI
ScienceOn
|
35 |
Cookson, W. 1999. The alliance of genes and environment in asthma and allergy. Nature. 402: B5-11 (Suppl.)
PUBMED
|
36 |
Hamm, S., J. Bleton, J. Connan, and A. Tchapla. 2005. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry. 66: 1499-1514
DOI
ScienceOn
|
37 |
Erin, E. M., T. J. Williams, P. J. Barnes, and T. T. Hansel. 2002. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr. Drug Targets Inflamm. Allergy. 1: 201-214
DOI
|
38 |
Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Cirt. Care. Med. 156: 766-775
DOI
ScienceOn
|
39 |
Yang, S. H., C. Y. Hong, and C. L. Yu. 2001. Decreased serum IgE level, decreased IFN-r and IL-5 but increased IL- 10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int. Immunopharmacol. 1: 1173-1182
DOI
ScienceOn
|
40 |
Gupta, I., V. Gupta, A. Parihar, S. Gupta, R. Lüdtke, H. Safayhi and H. P. Ammon. 1998. Effect of Boswellia serrata gum resin in patients with bronchial asthma: results of a double blind, placebo-control, 6-week clinical study. Eur. J. Med. Res. 3: 511-514
PUBMED
|
41 |
Sharma, M. L., A. Kaul, A., Khajuria, S. Singh, and G. B. Singh. 1996. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother. Res. 10: 107-112
DOI
|
42 |
Gleich, G. J. 2000. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105: 651-663
DOI
ScienceOn
|
43 |
Jain, V. V., K. Kitaqaki, T. Businqa, I. Hussain, C. Geroge, P. O'shauqhnessy, and J. N. Kline. 2002. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy Clin. Immunol. 110: 867-872
DOI
ScienceOn
|
44 |
Makino, S., and T. Fukuda. 1995. Eosinophils and allergy in asthma. Allergy Proc. 16: 13-21
|
45 |
Coyle, A. J., C. Bertrand, S. Tsuyuki, H. Pircher, S. Walti, G. Le Gros, and F. Erard. 1996. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann. N. Y. Acad. Sci. 796: 97-103
DOI
|
46 |
Marco, I., H. Hamida, M. van Nimwegen, K. Mirjam, V. Nanda, C. H. Henk, and N. L. Bart. 2006. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J. Clin. Invest. 116: 2935-2944
DOI
ScienceOn
|
47 |
Marx, J., E. Pretorius, and M. J. Bester. 2006. Effects of Urginea sanguinea, a traditional asthma remedy, on embryo neuronal development. J. Ethnopharmacol. 104: 315-321
DOI
ScienceOn
|
48 |
Takayuki, N., A. Yumiko, E. Michiko, N. Shin-yu, Y. Takeshi, and Y. Haruki. 2004. Anti-allergic acitivity of a Kampho (Japanese herbal) medicine "Sho-seiryu-to (Xiao- Qing-Long-Tang)" on airway inflammation in a mouse model. Int. Immunopharmacol. 4: 1353-1365
DOI
ScienceOn
|
49 |
Y., M. Dohi, R. Tanaka, A. Sato, K. Nakaqome, and K. Yamamoto. 2001. Early interleukin 4-dependent response can induce ariway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab. Invest. 81: 1385-1396
DOI
ScienceOn
|
50 |
Ram, A., U. Mabalirajan, M. Das, I. Bhattacharya, A. K. Dinda, S. V. Ganqal and B. Ghosh. 2006. Glycyrrhizin alleviates experimental allergic asthma in mice. Int. Immunopharmacol. 6: 1468-1477
DOI
ScienceOn
|
51 |
Larché, M., D. S. Robinson, and A. B. Kay. 2002. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111: 450-463
|
52 |
Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154: 5649-5655
PUBMED
|
53 |
Kung, T. T., D. Stelts, J. A. Zurcher, A. S. Watnick, H. Jones, P. J. Mauser, X. Fernandez, S. Umland, and W. Kreutne. 1994. Mechanisms of allergic pulmonary eosinophilia in the mouse. J. Allergy Clin. Immunol. 94: 1217-1224
DOI
ScienceOn
|
54 |
Roitt, I. M., J. Brostoff, and D. Male. 1989. Immunology. pp. 11-20. 2nd ed. Gower medical Publishing, London
|
55 |
Vignola, A. M., P. Chanez, A. M. Campbell, F. Souques, B. Lebel, I. Enander, and J. Bousquet. 1998. Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157: 403-409
DOI
PUBMED
ScienceOn
|
56 |
Barnes. P. J. 1999. Effect of bbb2-agonist on inflammatory cells. J. Allergy Clin. Immunol. 104: 10-17
DOI
ScienceOn
|
57 |
Hajhashemi, V., A. Ghannadi, and B. Sharif. 2003. Antiinflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J. Ethnopharmacol. 89: 67-71
DOI
ScienceOn
|
58 |
Kay, A. B., S. Ying, and S. R. Durham. 1995. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reaction. Int. Arch. Allergy Immunol. 107: 208-210
DOI
ScienceOn
|
59 |
Hart, P. H., C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finaly-Jones. 2000. Terpinen-4-ol, the main component of the essential oil of Melalecuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 49: 619-626
DOI
|
60 |
Kasakura, S. 1998. A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human disease. Rinsho. Byori. 46: 915-921
PUBMED
|